title: Alteration of the endometrial EGF profile as a potential mechanism connecting the alterations in the ovarian steroid hormone profile to embryonic loss in repeat breeders and high-producing cows.
abstract: Poor reproductive efficiency is a worldwide problem that has affected the dairy industry during the last several decades. In an attempt to explain the changes in reproductive physiology caused by high milk production, a model of elevated steroid metabolism in lactating dairy cows has been proposed. A slow increase in levels and low peak levels of estradiol (E₂) and progesterone (P₄) characterize endocrine changes in high producing cows. Similar changes have been reported in the repeat breeder cows. The abnormal changes in E₂ and P₄ concentrations of these cows may cause an improper uterine environment due to disturbed expression of growth factors and cytokines in the endometrium. This review focuses on the alteration in epidermal growth factor (EGF) profile in the endometrium during the estrous cycle. The normal cow has two peaks of EGF concentrations on days 2-4 and 13-14. Low concentrations of EGF on these days distinguished both high-producing and repeat breeder cows from normal cows. Alteration of the EGF profile could be found in 70 and 40% of the repeat breeder and high-producing cows, respectively. Treatment with a high dose of estradiol benzoate and an intravaginal progesterone-releasing device restored the normal EGF profile in about 70% of the affected cows. The cows having a normal EGF profile after treatment showed a higher pregnancy rate than the cows with the altered profile. Further studies to understand the etiology of the alteration in the EGF profile are needed to develop another treatment option and preventive management for this problem.
authors.affiliation: Laboratory of Theriogenology, Department of Large Animal Clinical Sciences, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu 069-8501, Japan.
authors.forename: Seiji
authors.initials: S
authors.lastname: Katagiri
authors.forename: Masaharu
authors.initials: M
authors.lastname: Moriyoshi
mesh_terms: D000282:Administration, Intravaginal; D000818:Animals; D002417:Cattle; D003612:Dairying; D004334:Drug Administration Schedule / Q000662:veterinary; D016503:Drug Delivery Systems / Q000662:veterinary; D004359:Drug Therapy, Combination / Q000662:veterinary; D020964:Embryo Loss / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control / Q000662:veterinary*; D004717:Endometrium / Q000187:drug effects / Q000378:metabolism*; D004815:Epidermal Growth Factor / Q000378:metabolism*; D004958:Estradiol / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use; D030762:Estrous Cycle / Q000187:drug effects; D005260:Female; D005300:Fertility Agents, Female / Q000008:administration & dosage / Q000627:therapeutic use; D007247:Infertility, Female / Q000209:etiology / Q000517:prevention & control / Q000662:veterinary*; D007315:Insemination, Artificial / Q000662:veterinary; D007774:Lactation / Q000187:drug effects; D008954:Models, Biological; D010053:Ovary / Q000187:drug effects / Q000378:metabolism*; D011247:Pregnancy; D011374:Progesterone / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use
chemical_list: D005300:Fertility Agents, Female; C074283:estradiol 3-benzoate; D011374:Progesterone; D004958:Estradiol; D004815:Epidermal Growth Factor